A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | XTLB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6.2 | $289.2 | 4% |
|
| Shares Out (Mil) | na | 54.1 | na |
|
| Institutional Ownership | 1.1% | 93.1% | 2% |
|
| Float (Mil) | 600.9 | 42.2 | 87% |
|
| Beta | 0.55 | 0.94 | 32% |
|
| Avg Daily Volume (000s) | 7 | 451 | 16% |
|
| Price Change (52-week) |
(47.5%) | 59.8% | 16% |
|
| Growth | XTLB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | (18.5%) | (10.1%) | 21% |
|
| EPS (5yr) | (5.9%) | 15.9% | 24 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 0.0% | (15.6%) | 64% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | XTLB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($7) | ($43) | 31% |
|
| EPS (TTM) | ($0.008) | ($1.500) | 39% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | ($31) | 31% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $6 | $190 | 6% |
|
| Valuation | XTLB | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.84 | na |
|
| P/E | na | 20.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | XTLB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (74.2%) | na |
|
| ROA | (320.3%) | (47.8%) | 1% |
|
| ROE | (372.2%) | (55.0%) | 2% |
|
| Liabilities to Assets | 253.0% | 29.7% | 99% |
|
| F-Score | 0 | 3 | na |
|
XTL Biopharmaceuticals Ltd. did not pass any screens on 9/3/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
